The oral activity seen in rodents cannot be directly mapped to human oral dosing without pharmacokinetic bridging studies, which do not exist for BPC-157
doi: 10.1128/MMBR.00001-18 160 Hernndez-OrtegaK.Garcia-EsparciaP.GilL.LucasJ
Responsible prescribing means proper patient selection, evidence-informed dosing, baseline and follow-up lab monitoring where appropriate, documented informed consent, and clinical follow-up to assess response
In a study conducted on rats, BPC 157 has demonstrated a wide range of protective activities in various organs and tissues, contributing to angiogenesis and showing extensive healing effects [2]
BPC-157 has been investigated in experimental settings involving ligament healing, contributing to growing interest in its potential role within regenerative medicine
Leaders should evaluate: Diversified sourcing strategies Depth of pharmacy compliance controls Contractual flexibility Real-time regulatory monitoring 3